BAX

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Baxter International Inc.

Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, it has been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.
CEO
Jose Almeida
Employees
2021
Headquarters

1 Baxter Pkwy
Deerfield, Illinois 60015-4625
Phone: 18479482000
www.baxter.com

News

Medical Nutrition Market to Hold a High Potential for Growth by 2028 | Abbott, Baxter, Danone S.A., Nestlé,
Aug 17, 2022 10:37am

Coherent Market Insights has blazoned new analysis on Medical Nutrition Market Status 2022- 2028 which has been prepared grounded on an in- depth request analysis with inputs from assiduity experts and top merchandisers within the business. The report covers the


Source:OpenPR
Baxter International Inc. – Consensus Indicates Potential 21.5% Upside
Aug 15, 2022 11:58am

Baxter International Inc. found using ticker (BAX) have now 13 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 100 and 60 with a mean TP of 72.85. With the stocks previous close at 59.97 this is indicating there is a potential upside of 21.5%. The 50 day moving average now sits at 65.06 while the 200 day moving average is 76.4. The company has a market cap of $30,448m. Visit the company website at: https://www.baxter.com [stock_market_widget type="chart" template="basic" color="green" assets="BAX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $36,988m based on the market concensus. Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit.


Source:DirectorsTalk
Executive Chairman Of Ameren Makes $5.03M Sale
Aug 12, 2022 14:18pm

Warner L Baxter , Executive Chairman at Ameren (NYSE: AEE ), reported a large insider sell on August 11, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Baxter sold 54,000 shares of Ameren . The total transaction amounted to $5,032,469. Ameren shares are trading up 0.72% at $94.71 at the time of this writing on Friday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. The Importance of Insider Transactions Insider transactions shouldn''t be used primarily to make … Full story available on Benzinga.com


Source:Benzinga
Baxter Stock''s Shares Are Starting To Look Cheap (NYSE:BAX)
Aug 11, 2022 16:55pm

Baxter boasts a broad portfolio of medically necessary products and therapies, and its brand strength is a key advantage. Click to read more.


Source:Seeking Alpha
Baxter International Inc. – Consensus Indicates Potential 25.8% Upside
Aug 08, 2022 12:52pm

Baxter International Inc. found using ticker (BAX) now have 13 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 100 and 60 calculating the mean target price we have 72.85. Given that the stocks previous close was at 57.91 this would indicate that there is a potential upside of 25.8%. There is a 50 day moving average of 66.63 and the 200 day MA is 76.95. The market capitalisation for the company is $29,507m. You can visit the company''s website by visiting: https://www.baxter.com [stock_market_widget type="chart" template="basic" color="green" assets="BAX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $37,119m based on the market concensus. Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit.


Source:DirectorsTalk
SEVEN EIGHT CAPITAL, LP Buys 2, Sells 3 in 2nd Quarter
Aug 04, 2022 19:00pm

Related Stocks: RBLX , SWN , NKE , WDAY , BAX ,


Source:GuruFocus
Thursday Upgrades Downgrades: Advanced Micro Devices, Baxter, Caesars, Electronic Arts, Gilead Sciences, Intel, JetBlue, Marriott, Match, Microchip Technology, Starbucks, Uber Technologies
Aug 04, 2022 12:56pm

day’s top analyst upgrades and downgrades included Advanced Micro Devices, Baxter International, Caesars Entertainment, Electronic Arts, Exact Sciences, Gilead Sciences, Intel, JetBlue Airways, Marriott International, Match Group, Microchip Technology, Starbucks and Uber Technologies.


Source:24/7 Wall street
Baxter International''s Return On Capital Employed Overview
Aug 02, 2022 14:04pm

According to Benzinga Pro, during Q2, Baxter International (NYSE: BAX ) earned $255.00 million, a 249.32% increase from the preceding quarter. Baxter International also posted a total of $3.75 billion in sales, a 1.05% increase since Q1. In Q1, Baxter International earned $73.00 million, and total sales reached $3.71 billion. What Is ROCE? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company''s ROCE. A higher ROCE is generally representative of successful growth of … Full story available on Benzinga.com


Source:Benzinga
Why Baxter International Stock Is Tumbling Today
Jul 28, 2022 16:18pm

Investors weren''t happy with the company''s Q2 update.


Source:The Motley Fool
Baxter Shares Plunge After Q2 Earnings Miss, Disappointing FY22 Guidance
Jul 28, 2022 16:07pm

Baxter International Inc (NYSE: BAX ) posted Q2 revenue of $3.75 billion , missing the consensus of $3.88 billion, up 21% on a reported basis, 26% on a constant currency basis, and 3% on an operational basis. Adjusted EPS of $0.87 increased 9%, in line with the consensus and the management guidance. Baxter''s newly acquired Hillrom businesses – Patient Support Systems, Front Line Care, and Surgical Solutions – contributed … Full story available on Benzinga.com


Source:Benzinga
Baxter International Inc. (BAX) CEO José Almeida on Q2 2022 Results - Earnings Call Transcript
Jul 28, 2022 15:06pm

Baxter International Inc. (NYSE:NYSE:BAX) Q2 2022 Results Earnings Conference Call July 28, 2022, 08:30 AM ET Company Participants Clare Trachtman - Vice President, Investor Relations José…


Source:Seeking Alpha
Stifel Reiterates Buy Rating on Baxter International
Jul 28, 2022 14:09pm

https://www.investing.com/news/pro/stifel-reiterates-buy-rating-on-baxter-international-432SI-2856955


Source:Investing.com
KeyBanc on Baxter International , Believes Investors are ''Dissappointed'' With Q2 2022 Earings Report and Guidance Update
Jul 28, 2022 14:05pm

https://www.investing.com/news/pro/keybanc-on-baxter-international--believes-investors-are-dissappointed-with-q2-2022-earings-report-and-guidance-update-432SI-2856952


Source:Investing.com
Baxter Non-GAAP EPS of $0.87 in-line, revenue of $3.75B misses by $130M, updates FY22 guidance
Jul 28, 2022 11:18am

Baxter press release (BAX): Q2 Non-GAAP EPS of $0.87 in-line.Revenue of $3.75B (+21.0% Y/Y) misses by $130M.Baxter now expects full-year 2022 sales growth to advance in the high teens…


Source:Seeking Alpha
Baxter Reports Second-Quarter 2022 Results
Jul 28, 2022 11:15am

Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2022. “Baxter’s diverse, durable portfolio of essential healthcare products powers our business, even amid unprecedented macroeconomic headwinds,” said José (Joe) E. Almeida, chairman, president and chief executive officer. “While we continue to navigate a dynamic near-term


Source:Wallstreet:Online
Baxter Q2 2022 Earnings Preview
Jul 27, 2022 16:29pm

Baxter (BAX) is scheduled to announce Q2 earnings results on Thursday, July 28th, before market open.The consensus EPS Estimate is $0.87 (+8.7% Y/Y) and the consensus Revenue Estimate…


Source:Seeking Alpha
Baxter International Inc. – Consensus Indicates Potential 28.5% Upside
Jul 25, 2022 10:18am

Baxter International Inc. found using ticker (BAX) have now 13 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 100 and 70 calculating the average target price we see 84.85. Given that the stocks previous close was at 66.03 this would indicate that there is a potential upside of 28.5%. The 50 day moving average now sits at 69.04 and the 200 moving average now moves to 77.88. The company has a market cap of $33,313m. Company Website: https://www.baxter.com [stock_market_widget type="chart" template="basic" color="green" assets="BAX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $42,809m based on the market concensus. Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit.


Source:DirectorsTalk
Handheld Technology from Baxter Makes Diabetic Retinopathy Screening Simple and Affordable for Primary Care Settings
Jul 25, 2022 00:30am

Early Detection Can Prevent 95% of Vision Loss Cases SEOUL, South Korea , July 25, 2022 /PRNewswire/ -- Diabetic retinopathy is the leading cause of blindness among working-age adults globally. 1 With early detection and treatment, as much as 95 percent of vision loss cases can be prevented. 2 Compliance with annual diabetic retinal exams in South Korea was found to be approximately 53%, with only 73% of those taking place in the last 12 months. 3 Up to 80% of individuals with type two diabetes may eventually develop some stage of diabetic retinopathy. 4 The Welch Allyn® RetinaVue™ 100 Imager PRO enables diabetic retinopathy screening in primary care settings. By quickly and comfortably screening patients as part of their routine primary care visit, it has been shown that RetinaVue can double patient compliance for potentially vision-saving annual diabetic retinal exams (DREs) in 12 months. 5 "Diabetes is an epidemic. Diabetic retinopathy is the leading cause of vision loss among adults 20-to-74 years of age, 6 affecting 7.7 million people worldwide. 7 It is simply tragic that a large percentage of patients with diabetes aren''t being screened for diabetic retinopathy, when it''s one of the most preventable causes of blindness among adults," said Bruce Peatey, Vice President of Baxter, Asia Pacific . "RetinaVue has the potential to change lives by helping to identify diabetic retinopathy in those individuals who had not previously been screened for the disease, enhancing the potential to save the sight of thousands, if not millions, of people with diabetes." Baxter makes this possible by reducing the cost barrier for high-quality fundus imaging.


Source:PR Newswire Asia (English)
Fluid Management Systems Market - Global Trajectory & Analytics to 2026 - ResearchAndMarkets.com
Jul 18, 2022 12:23pm


Source:Kwhen Finance
Baxter International Inc. – Consensus Indicates Potential 35.0% Upside
Jul 18, 2022 09:17am

Baxter International Inc. found using ticker (BAX) have now 13 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 100 and 70 and has a mean target at 85.62. Now with the previous closing price of 63.42 this would indicate that there is a potential upside of 35.0%. The 50 day MA is 69.8 and the 200 day MA is 78.26. The market cap for the company is $32,684m. You can visit the company''s website by visiting: https://www.baxter.com [stock_market_widget type="chart" template="basic" color="green" assets="BAX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $44,125m based on the market concensus. Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit.


Source:DirectorsTalk
Baxter: I Like The Industry, But Not The Stock
Jul 17, 2022 11:48am

Baxter International (BAX) underperformed its peers the past two years. Read more to see the Baxter''s potential headwinds and why I''m moving on from BAX stock.


Source:Seeking Alpha
New filing by BAXTER FOR CONGRESS
Jul 15, 2022 17:01pm

The BAXTER FOR CONGRESS successfully filed their F3N JULY QUARTERLY with the coverage period of 04/01/2022 to 06/30/2022 and a confirmation ID of FEC-1613172 *********CommitteeId: C00783720 | FilingId: 1613172 | FormType: F3N | CoverageFrom: 04/01/2022 | CoverageThrough: 06/30/2022 | ReportType: JULY QUARTERLY*********


Source:The FEC
Baxter declares $0.29 dividend (NYSE:BAX)
Jul 12, 2022 21:11pm

Baxter (NYSE:BAX) declares $0.29/share quarterly dividend, in line with previous.Forward yield 1.79%Payable Oct. 3; for shareholders of record Sept. 2; ex-div Sept.


Source:Seeking Alpha
Baxter International Inc. – Consensus Indicates Potential 32.7% Upside
Jul 11, 2022 12:31pm

Baxter International Inc. found using ticker (BAX) now have 13 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 100 and 70 with the average target price sitting at 86.54. Given that the stocks previous close was at 65.21 this now indicates there is a potential upside of 32.7%. The 50 day moving average now sits at 70.48 while the 200 day moving average is 78.68. The market cap for the company is $32,820m. You can visit the company''s website by visiting: https://www.baxter.com [stock_market_widget type="chart" template="basic" color="green" assets="BAX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $43,555m based on the market concensus. Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit.


Source:DirectorsTalk
‘I was on the high of highs, and suddenly it was over’: Linda Hoover on her great lost LP with Steely Dan
Jul 07, 2022 16:00pm

At the age of 71, singer-songwriter Hoover is finally releasing her debut album – 50 years after she made it. She explains how Becker and Fagen lent a hand to a must-have record for Dan fans Few wannabe pop stars release their debut album at the age of 71, especially one that was recorded more than half a century earlier. But Linda Hoover’s I Mean to Shine is no ordinary album. Not only does the backing group feature three future members of Steely Dan – Donald Fagen, Walter Becker and Jeff “Skunk” Baxter – it also includes five Becker-Fagen songs, all of them little-known and one of them never previously heard. This historic pop artefact has gathered dust for 52 years after her label boss withheld the release. “I was not emotionally prepared when I was told the album was being shelved, and I felt like it was my fault,” says Hoover today. “I knew nothing about the music business, or any business for that matter. I was rolling along on the high of highs and suddenly it was over.” Back in the 1960s, Hoover was just a New Jersey kid with big dreams.


Source:The Guardian
Huge Lays Off 37—About 3% of Its Workforce
Jul 06, 2022 19:39pm

Digital agency Huge is laying off about 3% of the agency, CEO Mat Baxter confirmed to Adweek today. Baxter told Adweek that the agency, which has about 1,200 employees across 12 global markets, made the cuts in response to the changing market and clients cutting spend. "We''re seeing clients either cancel, move or pause activities,"…


Source:Adweek
Baxter softball, baseball end season with first-round losses
Jul 05, 2022 04:47am

Bolts fall to Colo-NESCO, state-ranked Ankeny Christian Academy in postseason play


Source:Newton Daily News
Intravenous Solutions Market Will Generate Booming Growth Opportunities to 2032 | Baxter International Inc., Fresenius Kabi USA, LLC, Grifols, S.A., ICU Medical
Jun 28, 2022 06:26am

Global Intravenous Solutions Market Size, Status, and Forecast for the 2022-2032. Comprehensive analysis has been compiled to supply the foremost up-to-date data on key aspects of the market. This research report covers major aspects of the Intravenous Solutions industry, as well as drivers, restraints, PESTLE


Source:OpenPR
How Is The Market Feeling About Baxter Intl?
Jun 27, 2022 20:40pm

Baxter Intl''s (NYSE: BAX ) short percent of float has fallen 6.4% since its last report. The company recently reported that it has 5.89 million shares sold short , which is 1.17% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.8 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price … Full story available on Benzinga.com


Source:Benzinga
Friday’s Bounce Back: Analysts Upgrade or Downgrade Altria, Marathon Oil, Shopify and More
Jun 24, 2022 15:10pm

Friday''s additional top analyst upgrades and downgrades included Altria, Aurora Cannabis, Baxter International, Marathon Oil, Progressive and Shopify.


Source:24/7 Wall street
BAX stock lower as Wells Fargo downgrades citing near-term headwinds (NYSE:BAX)
Jun 24, 2022 12:19pm

Baxter International (BAX) is trading lower in the pre-market Friday on below-average volume after Wells Fargo downgraded the health equipment maker to Equal Weight from Overweight,…


Source:Seeking Alpha
US FDA Labels Baxter’s Respiratory Device Recall as Most Serious
Jun 24, 2022 08:10am

The U.S. Food and Drug Administration on Thursday classified the recall of some Baxter International Inc’s lung therapy devices as the most serious type after reports of two deaths. Medical device maker Baxter in late April recalled about 268 devices distributed between May 28, 2020 and April 19, 2022. The device, Volara, is used to […]


Source:The Epoch Times
Baxter International (BAX) Investor Presentation - Slideshow (NYSE:BAX)
Jun 19, 2022 17:47pm

The following slide deck was published by Baxter International Inc.


Source:Seeking Alpha